Disease Prevalence Matters: Challenge for SARS-CoV-2 Testing.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 4, p. 50, doi. 10.3390/antib10040050
- By:
- Publication type:
- Article
Works matching IS 20734468 AND DT 2021 AND VI 10 AND IP 4
Results: 15
1
2
Allergen-Specific IgE and IgG4 as Biomarkers for Immunologic Changes during Subcutaneous Allergen Immunotherapy.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 4, p. 49, doi. 10.3390/antib10040049
- By:
- Publication type:
- Article
3
Immunological Separation of Bioactive Natural Compounds from Crude Drug Extract and Its Application for Cell-Based Studies.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 4, p. 48, doi. 10.3390/antib10040048
- By:
- Publication type:
- Article
4
Central Nervous System Delivery of Antibodies and Their Single-Domain Antibodies and Variable Fragment Derivatives with Focus on Intranasal Nose to Brain Administration.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 4, p. 47, doi. 10.3390/antib10040047
- By:
- Publication type:
- Article
5
Characterization of Anti-Ana o 3 Monoclonal Antibodies and Their Application in Comparing Brazilian Cashew Cultivars.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 4, p. 46, doi. 10.3390/antib10040046
- By:
- Publication type:
- Article
6
Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 4, p. 45, doi. 10.3390/antib10040045
- By:
- Publication type:
- Article
7
Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 4, p. 44, doi. 10.3390/antib10040044
- By:
- Publication type:
- Article
8
Studies on Natural Products Using Monoclonal Antibodies: A Review.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 4, p. 43, doi. 10.3390/antib10040043
- By:
- Publication type:
- Article
9
Introduction to Antibody-Drug Conjugates.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 4, p. 42, doi. 10.3390/antib10040042
- By:
- Publication type:
- Article
10
IL-33, IL-37, and Vitamin D Interaction Mediate Immunomodulation of Inflammation in Degenerating Cartilage †.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 4, p. 41, doi. 10.3390/antib10040041
- By:
- Publication type:
- Article
11
Effect of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Antibody–Drug Conjugates (ADCs).
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 4, p. 40, doi. 10.3390/antib10040040
- By:
- Publication type:
- Article
12
Novel Selection Approaches to Identify Antibodies Targeting Neoepitopes on the C5b6 Intermediate Complex to Inhibit Membrane Attack Complex Formation.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 4, p. 39, doi. 10.3390/antib10040039
- By:
- Publication type:
- Article
13
Engineered mRNA and the Rise of Next-Generation Antibodies.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 4, p. 37, doi. 10.3390/antib10040037
- By:
- Publication type:
- Article
14
From Anti-SARS-CoV-2 Immune Response to the Cytokine Storm via Molecular Mimicry.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 4, p. 36, doi. 10.3390/antib10040036
- By:
- Publication type:
- Article
15
Expression and Display of Glycoengineered Antibodies and Antibody Fragments with an Engineered Yeast Strain.
- Published in:
- Antibodies (2073-4468), 2021, v. 10, n. 4, p. 38, doi. 10.3390/antib10040038
- By:
- Publication type:
- Article